SCHEMBL6985545

SCHEMBL6985545

CC(C)(C)[C](Cc1ccccc1)c1ccc(F)cc1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
RAB9A P51151 3/20 0.42
KDM4E B2RXH2 3/20 0.42
NPC1 O15118 2/20 0.41
CNR2 P34972 1/20 0.41
CES1 P23141 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
PLA2G1B P04054 1/20 0.39
ATG4B Q9Y4P1 1/20 0.39
LMNA P02545 1/20 0.38
MAPK1 P28482 1/20 0.38
CASP3 P42574 1/20 0.38
SENP7 Q9BQF6 1/20 0.38
SENP6 Q9GZR1 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6981681 0.76 ALDH1A1 (0.55) ALDH1A1L3MBTL1SMN1; SMN2RAB9AKDM4E
SCHEMBL6989270 0.73 ALDH1A1 (0.51) ALDH1A1L3MBTL1SMN1; SMN2RAB9AKDM4E
SCHEMBL12722992 0.72 ALDH1A1 (0.50) ALDH1A1L3MBTL1SMN1; SMN2RAB9AKDM4E
SCHEMBL682591 0.72 L3MBTL1 (0.67) ALDH1A1L3MBTL1SMN1; SMN2RAB9AKDM4E
SCHEMBL9131500 0.71 ALDH1A1 (0.49) ALDH1A1L3MBTL1SMN1; SMN2RAB9AKDM4E
SCHEMBL6980719 0.71 NPC1 (0.43) SMN1; SMN2RAB9ANPC1CES1LMNA
SCHEMBL11506720 0.71 CES1 (0.55) ALDH1A1L3MBTL1CES1MAPK1
SCHEMBL10589621 0.70 TAAR1 (0.41) ALDH1A1RAB9ACES1CYP2C9CYP2C19
SCHEMBL4586342 0.69 ALDH1A1 (0.51) ALDH1A1L3MBTL1SMN1; SMN2RAB9AKDM4E
SCHEMBL4586337 0.69 ALDH1A1 (0.51) ALDH1A1L3MBTL1SMN1; SMN2RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1294695-A2 SUBSTITUTED DIAMIDE DERIVATIVES USEFUL AS MOTILIN ANTAGONISTS Ortho-McNeil Pharmaceutical, Inc. (US) 2003-03-26 EP claimed
WO-2001085694-A2 SUBSTITUTED DIAMIDE DERIVATIVES USEFUL AS MOTILIN ANTAGONISTS ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2001-11-15 WO claimed
EP-1294695-A2 SUBSTITUTED DIAMIDE DERIVATIVES USEFUL AS MOTILIN ANTAGONISTS Ortho-McNeil Pharmaceutical, Inc. (US) 2003-03-26 EP disclosed
WO-2001085694-A2 SUBSTITUTED DIAMIDE DERIVATIVES USEFUL AS MOTILIN ANTAGONISTS ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2001-11-15 WO disclosed